CELLDEMIC sol inj 7.5 µg 0.5 ml PFS 10 pce

7680699480012 CH-69948 J07BB02 08.08.

No images available

Details

Product number
6994801
CPT
-
Packaging group
10
Unit
Fertigspritze(n)
Composition
haemagglutininum influenzae A (H5N1) (Virus-Stamm A/turkey/Turkey/1/2005 NIBRG-23) 7.5 µg, adjuvans: squalenum, polysorbatum 80 1.175 mg, sorbitani trioleas, natrii citras dihydricus et acidum citricum, natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, aqua ad iniectabile, q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.88 mg, kalium 0.1 mg.

Articles (1)

Celldemic, Injektionssuspension in Fertigspritzen
Injektionssuspension
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
29/08/2026
Professional SmPC
Français
29/08/2026
Professional SmPC
Italien
29/08/2026

Detailed composition

Substance Quantity Type Category
haemagglutininum influenzae A (H5N1)
7.5 UG Substance Wirkstoff (Principe actif)
squalenum
- Substance HNIDK
polysorbatum 80
1.175 MG Substance HBESI
sorbitani trioleas
- Substance HNIDK
natrii citras dihydricus
- Substance HNIDK
acidum citricum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
kalii chloridum
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
dinatrii phosphas dihydricus
- Substance HNIDK
magnesii chloridum hexahydricum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.88 MG Substance HBESI
kalium
0.1 MG Substance HBESI

Authorization holder

Vifor (International) Inc.

9014 St. Gallen

Authorization information

Swissmedic authorization number
69948
Drug name
Celldemic, Injektionssuspension in Fertigspritzen
Galenic form
INJFS
ATC Code
J07BB02
Authorization status
Z
Dispensation category
B
First authorization
25/06/2026
Authorization expiration date
24/06/2031
IT number
08.08.
Domain
Human medicine
Field of application
Aktive Immunisierung von Erwachsenen und Kindern ab 6 Monaten zur Prophylaxe einer Influenza, verursacht durch das Influenza-A-Virus des Subtyps H5N1

Packaging details

Description (FR)
CELLDEMIC sol inj 7.5 µg 0.5 ml PFS 10 pce
Description (DE)
CELLDEMIC Inj Lös 7.5 µg 0.5 ml PFS 10 Stk
Market launch
01/06/2029
Narcotic (BTM)
No
Buy us a coffee Explore the data